Iovance Biotherapeutics Inc (IOVA)
7.96
-0.04
(-0.50%)
USD |
NASDAQ |
Jun 20, 16:00
8.00
+0.04
(+0.50%)
After-Hours: 20:00
Iovance Biotherapeutics Total Return Level: 8.00 for June 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 18, 2024 | 8.00 |
June 17, 2024 | 8.08 |
June 14, 2024 | 8.16 |
June 13, 2024 | 8.43 |
June 12, 2024 | 8.53 |
June 11, 2024 | 8.62 |
June 10, 2024 | 8.055 |
June 07, 2024 | 7.78 |
June 06, 2024 | 8.14 |
June 05, 2024 | 8.32 |
June 04, 2024 | 8.10 |
June 03, 2024 | 8.37 |
May 31, 2024 | 8.88 |
May 30, 2024 | 9.00 |
May 29, 2024 | 9.28 |
May 28, 2024 | 9.70 |
May 24, 2024 | 10.01 |
May 23, 2024 | 10.26 |
May 22, 2024 | 10.33 |
May 21, 2024 | 10.32 |
May 20, 2024 | 10.35 |
May 17, 2024 | 10.24 |
May 16, 2024 | 10.43 |
May 15, 2024 | 10.68 |
May 14, 2024 | 10.72 |
Date | Value |
---|---|
May 13, 2024 | 10.88 |
May 10, 2024 | 10.96 |
May 09, 2024 | 13.45 |
May 08, 2024 | 13.39 |
May 07, 2024 | 13.98 |
May 06, 2024 | 13.88 |
May 03, 2024 | 13.63 |
May 02, 2024 | 12.88 |
May 01, 2024 | 12.50 |
April 30, 2024 | 11.78 |
April 29, 2024 | 12.03 |
April 26, 2024 | 11.64 |
April 25, 2024 | 11.54 |
April 24, 2024 | 11.71 |
April 23, 2024 | 11.86 |
April 22, 2024 | 11.32 |
April 19, 2024 | 11.31 |
April 18, 2024 | 11.72 |
April 17, 2024 | 11.80 |
April 16, 2024 | 11.92 |
April 15, 2024 | 11.89 |
April 12, 2024 | 12.36 |
April 11, 2024 | 13.19 |
April 10, 2024 | 12.58 |
April 09, 2024 | 13.22 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.30
Minimum
Oct 19 2023
52.59
Maximum
Feb 08 2021
19.29
Average
18.15
Median
Oct 09 2019
Total Return Level Benchmarks
Viatris Inc | 13.94 |
Beam Therapeutics Inc | 23.17 |
Revolution Medicines Inc | 37.72 |
Day One Biopharmaceuticals Inc | 13.39 |
Viking Therapeutics Inc | 50.64 |